$LJPC Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LA JOLLA PHARMACEUTICAL CO.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in LA JOLLA PHARMACEUTICAL CO. Get notifications about new insider transactions in LA JOLLA PHARMACEUTICAL CO for free.
Page: < prev 1 ... 2 3 4 5 6 7 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 12 2009 | LJPC | LA JOLLA PHARMACEU ... | Frazier Healthcare V, LP | 10% Owner | Buy | P | 1.89 | 1,039,378 | 1,964,424 | 5,872,711 | 4.8 M to 5.9 M (+21.50 %) |
Jan 23 2009 | LJPC | LA JOLLA PHARMACEU ... | SEIKKULA LUKE | Vice President Manu ... | Option Exercise | A | 1.26 | 35,000 | 44,100 | 35,000 | |
Jan 23 2009 | LJPC | LA JOLLA PHARMACEU ... | SLOAN GAIL A | VP of Finance | Option Exercise | A | 1.26 | 25,000 | 31,500 | 25,000 | |
Jan 23 2009 | LJPC | LA JOLLA PHARMACEU ... | Elchico Josefina T | VP Quality Operatio ... | Option Exercise | A | 1.26 | 35,000 | 44,100 | 35,000 | |
Jan 23 2009 | LJPC | LA JOLLA PHARMACEU ... | TANSEY MICHAEL JAMES BYRON | Executive VP & CMO | Option Exercise | A | 1.26 | 45,000 | 56,700 | 45,000 | |
Jan 23 2009 | LJPC | LA JOLLA PHARMACEU ... | CAVIAR NIV EDWARD | Chief Business Offi ... | Option Exercise | A | 1.26 | 55,000 | 69,300 | 55,000 | |
Jan 23 2009 | LJPC | LA JOLLA PHARMACEU ... | Gillespie Deirdre | President & CEO | Option Exercise | A | 1.26 | 150,000 | 189,000 | 150,000 | |
Jan 23 2009 | LJPC | LA JOLLA PHARMACEU ... | SUTTER MARTIN P | Director | Sell | P | 1.50 | 26,091 | 39,137 | 112,880 | 139 K to 112.9 K (-18.77 %) |
Jan 23 2009 | LJPC | LA JOLLA PHARMACEU ... | SUTTER MARTIN P | Director | Sell | P | 1.46 | 5,000 | 7,300 | 86,789 | 91.8 K to 86.8 K (-5.45 %) |
Jan 23 2009 | LJPC | LA JOLLA PHARMACEU ... | SUTTER MARTIN P | Director | Buy | P | 1.40 | 41,409 | 57,894 | 81,789 | 40.4 K to 81.8 K (+102.55 %) |
Jan 23 2009 | LJPC | LA JOLLA PHARMACEU ... | SUTTER MARTIN P | Director | Buy | P | 1.33 | 27,500 | 36,710 | 40,380 | 12.9 K to 40.4 K (+213.51 %) |
May 23 2008 | LJPC | LA JOLLA PHARMACEU ... | ADAMS THOMAS PHD | Director | Option Exercise | A | 1.82 | 10,000 | 18,200 | 10,000 | |
May 23 2008 | LJPC | LA JOLLA PHARMACEU ... | TANSEY MICHAEL JAMES BYRON | Executive VP & CMO | Option Exercise | A | 1.87 | 200,000 | 374,000 | 200,000 | |
May 23 2008 | LJPC | LA JOLLA PHARMACEU ... | SEIKKULA LUKE | Vice President Manu ... | Option Exercise | A | 1.87 | 75,000 | 140,250 | 75,000 | |
May 23 2008 | LJPC | LA JOLLA PHARMACEU ... | YOUNG FRANK | Director | Option Exercise | A | 1.82 | 10,000 | 18,200 | 10,000 | |
May 23 2008 | LJPC | LA JOLLA PHARMACEU ... | Topper James N | Director | Option Exercise | A | 1.82 | 10,000 | 18,200 | 10,000 | |
May 23 2008 | LJPC | LA JOLLA PHARMACEU ... | SUTTER MARTIN P | Director | Option Exercise | A | 1.82 | 10,000 | 18,200 | 10,000 | |
May 23 2008 | LJPC | LA JOLLA PHARMACEU ... | SMITH CRAIG R | Director | Option Exercise | A | 1.82 | 20,000 | 36,400 | 20,000 | |
May 23 2008 | LJPC | LA JOLLA PHARMACEU ... | SMITH CRAIG R | Director | Option Exercise | A | 1.82 | 10,000 | 18,200 | 10,000 | |
May 23 2008 | LJPC | LA JOLLA PHARMACEU ... | MARTIN STEPHEN | Director | Option Exercise | A | 1.82 | 10,000 | 18,200 | 10,000 | |
May 23 2008 | LJPC | LA JOLLA PHARMACEU ... | FILDES ROBERT PHD | Director | Option Exercise | A | 1.82 | 10,000 | 18,200 | 10,000 | |
May 15 2008 | LJPC | LA JOLLA PHARMACEU ... | Gonzalez Alejandro | 10% Owner | Option Exercise | P | 0.13 | 404,814 | 50,602 | 1,138,147 | |
May 15 2008 | LJPC | LA JOLLA PHARMACEU ... | Gonzalez Alejandro | 10% Owner | Buy | P | 1.89 | 1,619,256 | 3,060,394 | 8,205,692 | 6.6 M to 8.2 M (+24.58 %) |
May 14 2008 | LJPC | LA JOLLA PHARMACEU ... | SUTTER MARTIN P | Director | Option Exercise | P | 0.13 | 1,951,854 | 243,982 | 1,951,854 | |
May 14 2008 | LJPC | LA JOLLA PHARMACEU ... | SUTTER MARTIN P | Director | Buy | P | 1.89 | 7,807,415 | 14,756,014 | 7,807,415 | 0 to 7.8 M |
May 14 2008 | LJPC | LA JOLLA PHARMACEU ... | SUTTER MARTIN P | Director | Option Exercise | P | 0.13 | 520,494 | 65,062 | 2,187,160 | |
May 14 2008 | LJPC | LA JOLLA PHARMACEU ... | SUTTER MARTIN P | Director | Buy | P | 1.89 | 2,081,977 | 3,934,937 | 9,748,643 | 7.7 M to 9.7 M (+27.16 %) |
May 14 2008 | LJPC | LA JOLLA PHARMACEU ... | ESSEX WOODLANDS HEALTH VENTURE ... | 10% Owner | Option Exercise | P | 0.13 | 1,951,854 | 243,982 | 1,951,854 | |
May 14 2008 | LJPC | LA JOLLA PHARMACEU ... | ESSEX WOODLANDS HEALTH VENTURE ... | 10% Owner | Buy | P | 1.89 | 7,807,415 | 14,756,014 | 7,807,415 | 0 to 7.8 M |
May 14 2008 | LJPC | LA JOLLA PHARMACEU ... | ESSEX WOODLANDS HEALTH VENTURE ... | 10% Owner | Option Exercise | P | 0.13 | 520,494 | 65,062 | 2,187,160 | |
May 14 2008 | LJPC | LA JOLLA PHARMACEU ... | ESSEX WOODLANDS HEALTH VENTURE ... | 10% Owner | Buy | P | 1.89 | 2,081,977 | 3,934,937 | 9,748,643 | 7.7 M to 9.7 M (+27.16 %) |
Mar 11 2008 | LJPC | LA JOLLA PHARMACEU ... | Gonzalez Alejandro | 10% Owner | Buy | P | 2.12 | 551,100 | 1,168,332 | 6,586,436 | 6 M to 6.6 M (+9.13 %) |
Feb 25 2008 | LJPC | LA JOLLA PHARMACEU ... | SLOAN GAIL A | VP of Finance | Option Exercise | A | 2.42 | 25,000 | 60,500 | 25,000 | |
Feb 25 2008 | LJPC | LA JOLLA PHARMACEU ... | TANSEY MICHAEL JAMES BYRON | Executive VP & CMO | Option Exercise | A | 2.42 | 40,000 | 96,800 | 40,000 | |
Feb 25 2008 | LJPC | LA JOLLA PHARMACEU ... | SEIKKULA LUKE | Vice President Manu ... | Option Exercise | A | 2.42 | 25,000 | 60,500 | 25,000 | |
Feb 25 2008 | LJPC | LA JOLLA PHARMACEU ... | Gillespie Deirdre | President & CEO | Option Exercise | A | 2.42 | 150,000 | 363,000 | 150,000 | |
Feb 25 2008 | LJPC | LA JOLLA PHARMACEU ... | Elchico Josefina T | VP Quality Operatio ... | Option Exercise | A | 2.42 | 25,000 | 60,500 | 25,000 | |
Feb 25 2008 | LJPC | LA JOLLA PHARMACEU ... | CAVIAR NIV EDWARD | Chief Business Offi ... | Option Exercise | A | 2.42 | 50,000 | 121,000 | 50,000 | |
Dec 21 2007 | LJPC | LA JOLLA PHARMACEU ... | Elchico Josefina T | VP Quality Operatio ... | Sell | S | 3.90 | 400 | 1,560 | 17,847 | 18.2 K to 17.8 K (-2.19 %) |
Dec 18 2007 | LJPC | LA JOLLA PHARMACEU ... | Gonzalez Alejandro | 10% Owner | Buy | P | 3.93 | 50,000 | 196,310 | 6,035,336 | 6 M to 6 M (+0.84 %) |
Dec 17 2007 | LJPC | LA JOLLA PHARMACEU ... | Gonzalez Alejandro | 10% Owner | Buy | P | 3.65 | 57,508 | 209,933 | 5,985,336 | 5.9 M to 6 M (+0.97 %) |
Sep 12 2007 | LJPC | LA JOLLA PHARMACEU ... | Gonzalez Alejandro | 10% Owner | Buy | P | 4.45 | 75,000 | 333,750 | 5,927,828 | 5.9 M to 5.9 M (+1.28 %) |
Sep 11 2007 | LJPC | LA JOLLA PHARMACEU ... | Gonzalez Alejandro | 10% Owner | Buy | P | 4.45 | 10,000 | 44,500 | 5,852,828 | 5.8 M to 5.9 M (+0.17 %) |
Sep 04 2007 | LJPC | LA JOLLA PHARMACEU ... | Gonzalez Alejandro | 10% Owner | Buy | P | 4.27 | 13,000 | 55,510 | 5,842,828 | 5.8 M to 5.8 M (+0.22 %) |
Jun 15 2007 | LJPC | LA JOLLA PHARMACEU ... | Gonzalez Alejandro | 10% Owner | Buy | P | 4.65 | 189,716 | 882,179 | 5,829,828 | 5.6 M to 5.8 M (+3.36 %) |
Jun 15 2007 | LJPC | LA JOLLA PHARMACEU ... | Gonzalez Alejandro | 10% Owner | Buy | P | 4.64 | 26,646 | 123,637 | 5,640,112 | 5.6 M to 5.6 M (+0.47 %) |
Jun 15 2007 | LJPC | LA JOLLA PHARMACEU ... | Gonzalez Alejandro | 10% Owner | Buy | P | 4.63 | 63,291 | 293,037 | 5,613,466 | 5.6 M to 5.6 M (+1.14 %) |
Jun 15 2007 | LJPC | LA JOLLA PHARMACEU ... | Gonzalez Alejandro | 10% Owner | Buy | P | 4.62 | 4,200 | 19,404 | 5,550,175 | 5.5 M to 5.6 M (+0.08 %) |
Jun 15 2007 | LJPC | LA JOLLA PHARMACEU ... | Gonzalez Alejandro | 10% Owner | Buy | P | 4.61 | 37,500 | 172,875 | 5,545,975 | 5.5 M to 5.5 M (+0.68 %) |
Jun 15 2007 | LJPC | LA JOLLA PHARMACEU ... | Gonzalez Alejandro | 10% Owner | Buy | P | 4.60 | 11,647 | 53,576 | 5,508,475 | 5.5 M to 5.5 M (+0.21 %) |
Jun 15 2007 | LJPC | LA JOLLA PHARMACEU ... | Gonzalez Alejandro | 10% Owner | Buy | P | 4.59 | 67,000 | 307,530 | 5,496,828 | 5.4 M to 5.5 M (+1.23 %) |
May 24 2007 | LJPC | LA JOLLA PHARMACEU ... | MARTIN STEPHEN | Director | Option Exercise | A | 5.97 | 10,000 | 59,700 | 10,000 | |
May 24 2007 | LJPC | LA JOLLA PHARMACEU ... | YOUNG FRANK | Director | Option Exercise | A | 5.97 | 10,000 | 59,700 | 10,000 | |
May 24 2007 | LJPC | LA JOLLA PHARMACEU ... | SUTTER MARTIN P | Director | Option Exercise | A | 5.97 | 10,000 | 59,700 | 10,000 | |
May 24 2007 | LJPC | LA JOLLA PHARMACEU ... | Naini Nader J | Director | Option Exercise | A | 5.97 | 10,000 | 59,700 | 10,000 | |
May 24 2007 | LJPC | LA JOLLA PHARMACEU ... | SMITH CRAIG R | Director | Option Exercise | A | 5.97 | 10,000 | 59,700 | 10,000 | |
May 24 2007 | LJPC | LA JOLLA PHARMACEU ... | SMITH CRAIG R | Director | Option Exercise | A | 5.97 | 20,000 | 119,400 | 20,000 | |
May 24 2007 | LJPC | LA JOLLA PHARMACEU ... | SUTTER MARTIN P | Director | Option Exercise | A | 5.97 | 10,000 | 59,700 | 10,000 | |
May 24 2007 | LJPC | LA JOLLA PHARMACEU ... | FILDES ROBERT PHD | Director | Option Exercise | A | 5.97 | 10,000 | 59,700 | 10,000 | |
May 24 2007 | LJPC | LA JOLLA PHARMACEU ... | ADAMS THOMAS PHD | Director | Option Exercise | A | 5.97 | 10,000 | 59,700 | 10,000 | |
May 24 2007 | LJPC | LA JOLLA PHARMACEU ... | Topper James N | Director | Option Exercise | A | 5.97 | 10,000 | 59,700 | 10,000 | |
May 24 2007 | LJPC | LA JOLLA PHARMACEU ... | TANSEY MICHAEL JAMES BYRON | Executive VP & CMO | Option Exercise | A | 5.47 | 50,000 | 273,500 | 50,000 | |
May 11 2007 | LJPC | LA JOLLA PHARMACEU ... | CAVIAR NIV EDWARD | Chief Business Offi ... | Option Exercise | A | 5.36 | 180,000 | 964,800 | 180,000 | |
Apr 12 2007 | LJPC | LA JOLLA PHARMACEU ... | ESSEX WOODLANDS HEALTH VENTURE ... | 10% Owner | Buy | P | 6.00 | 1,000,000 | 6,000,000 | 7,666,666 | 6.7 M to 7.7 M (+15.00 %) |
Apr 09 2007 | LJPC | LA JOLLA PHARMACEU ... | Gonzalez Alejandro | 10% Owner | Buy | P | 6.00 | 833,333 | 4,999,998 | 5,429,828 | 4.6 M to 5.4 M (+18.13 %) |
Apr 09 2007 | LJPC | LA JOLLA PHARMACEU ... | Frazier Healthcare V, LP | 10% Owner | Buy | P | 6.00 | 833,333 | 4,999,998 | 4,833,333 | 4 M to 4.8 M (+20.83 %) |
Apr 06 2007 | LJPC | LA JOLLA PHARMACEU ... | SUTTER MARTIN P | Director | Buy | P | 6.00 | 1,000,000 | 6,000,000 | 7,666,666 | 6.7 M to 7.7 M (+15.00 %) |
Apr 06 2007 | LJPC | LA JOLLA PHARMACEU ... | Naini Nader J | Director | Buy | P | 6.00 | 833,333 | 4,999,998 | 4,833,333 | 4 M to 4.8 M (+20.83 %) |
Apr 06 2007 | LJPC | LA JOLLA PHARMACEU ... | Topper James N | Director | Buy | P | 6.00 | 833,333 | 4,999,998 | 4,833,333 | 4 M to 4.8 M (+20.83 %) |
Mar 16 2007 | LJPC | LA JOLLA PHARMACEU ... | SMITH CRAIG R | Director | Grant | A | 0.00 | 3,600 | 0 | 27,200 | 23.6 K to 27.2 K (+15.25 %) |
Feb 07 2007 | LJPC | LA JOLLA PHARMACEU ... | KOCH LISA I | VP Regulatory & Pro ... | Option Exercise | A | 3.08 | 12,500 | 38,500 | 12,500 | |
Feb 07 2007 | LJPC | LA JOLLA PHARMACEU ... | WISEMAN ANDREW | Sen Dir Investor Re ... | Option Exercise | A | 3.08 | 25,000 | 77,000 | 25,000 | |
Feb 07 2007 | LJPC | LA JOLLA PHARMACEU ... | WISEMAN ANDREW | Sen Dir Investor Re ... | Buy | J | 2.58 | 155 | 399 | 16,613 | 16.5 K to 16.6 K (+0.94 %) |
Feb 07 2007 | LJPC | LA JOLLA PHARMACEU ... | WISEMAN ANDREW | Sen Dir Investor Re ... | Buy | J | 3.06 | 153 | 468 | 16,458 | 16.3 K to 16.5 K (+0.94 %) |
Feb 07 2007 | LJPC | LA JOLLA PHARMACEU ... | WISEMAN ANDREW | Sen Dir Investor Re ... | Buy | J | 3.06 | 131 | 401 | 16,305 | 16.2 K to 16.3 K (+0.81 %) |
Feb 07 2007 | LJPC | LA JOLLA PHARMACEU ... | SLOAN GAIL A | VP of Finance | Option Exercise | A | 3.08 | 25,000 | 77,000 | 25,000 | |
Feb 07 2007 | LJPC | LA JOLLA PHARMACEU ... | SLOAN GAIL A | VP of Finance | Buy | J | 0.00 | 2,230 | 0 | 2,230 | 0 to 2.2 K |
Feb 07 2007 | LJPC | LA JOLLA PHARMACEU ... | SLOAN GAIL A | VP of Finance | Buy | J | 2.58 | 159 | 410 | 4,245 | 4.1 K to 4.2 K (+3.89 %) |
Feb 07 2007 | LJPC | LA JOLLA PHARMACEU ... | SLOAN GAIL A | VP of Finance | Buy | J | 3.06 | 156 | 477 | 4,086 | 3.9 K to 4.1 K (+3.97 %) |
Feb 07 2007 | LJPC | LA JOLLA PHARMACEU ... | SLOAN GAIL A | VP of Finance | Buy | J | 3.06 | 278 | 851 | 3,930 | 3.7 K to 3.9 K (+7.61 %) |
Feb 07 2007 | LJPC | LA JOLLA PHARMACEU ... | TANSEY MICHAEL JAMES BYRON | Executive VP & CMO | Buy | P | 3.10 | 700 | 2,170 | 1,900 | 1.2 K to 1.9 K (+58.33 %) |
Feb 07 2007 | LJPC | LA JOLLA PHARMACEU ... | TANSEY MICHAEL JAMES BYRON | Executive VP & CMO | Buy | P | 3.11 | 1,200 | 3,732 | 1,200 | 0 to 1.2 K |
Feb 07 2007 | LJPC | LA JOLLA PHARMACEU ... | Gillespie Deirdre | President & CEO | Option Exercise | A | 3.08 | 150,000 | 462,000 | 150,000 | |
Feb 07 2007 | LJPC | LA JOLLA PHARMACEU ... | Elchico Josefina T | VP Quality Operatio ... | Option Exercise | A | 3.08 | 19,000 | 58,520 | 19,000 | |
Feb 07 2007 | LJPC | LA JOLLA PHARMACEU ... | Elchico Josefina T | VP Quality Operatio ... | Buy | J | 2.58 | 1,736 | 4,471 | 12,199 | 10.5 K to 12.2 K (+16.59 %) |
Feb 07 2007 | LJPC | LA JOLLA PHARMACEU ... | Elchico Josefina T | VP Quality Operatio ... | Buy | J | 3.06 | 1,736 | 5,312 | 10,463 | 8.7 K to 10.5 K (+19.89 %) |
Feb 07 2007 | LJPC | LA JOLLA PHARMACEU ... | Elchico Josefina T | VP Quality Operatio ... | Buy | J | 3.06 | 1,736 | 5,312 | 8,727 | 7 K to 8.7 K (+24.83 %) |
Jan 11 2007 | LJPC | LA JOLLA PHARMACEU ... | JENN PAUL | VP of Product Devel ... | Sell | S | 3.09 | 6,630 | 20,460 | 350 | 7 K to 350 (-94.99 %) |
Jan 11 2007 | LJPC | LA JOLLA PHARMACEU ... | JENN PAUL | VP of Product Devel ... | Buy | J | 2.58 | 176 | 453 | 6,980 | 6.8 K to 7 K (+2.59 %) |
Jan 11 2007 | LJPC | LA JOLLA PHARMACEU ... | KOCH LISA I | Sr Dir Regulatory A ... | Sell | S | 3.02 | 652 | 1,972 | 6,350 | 7 K to 6.4 K (-9.31 %) |
Jan 11 2007 | LJPC | LA JOLLA PHARMACEU ... | KOCH LISA I | Sr Dir Regulatory A ... | Sell | S | 3.05 | 3,500 | 10,665 | 7,002 | 10.5 K to 7 K (-33.33 %) |
Jan 11 2007 | LJPC | LA JOLLA PHARMACEU ... | KOCH LISA I | Sr Dir Regulatory A ... | Buy | J | 2.58 | 251 | 646 | 10,502 | 10.3 K to 10.5 K (+2.45 %) |
Jan 10 2007 | LJPC | LA JOLLA PHARMACEU ... | Gonzalez Alejandro | 10% Owner | Buy | P | 3.12 | 25,000 | 78,000 | 4,596,495 | 4.6 M to 4.6 M (+0.55 %) |
Jan 10 2007 | LJPC | LA JOLLA PHARMACEU ... | Gonzalez Alejandro | 10% Owner | Buy | P | 3.12 | 8,600 | 26,832 | 4,571,495 | 4.6 M to 4.6 M (+0.19 %) |
Jan 10 2007 | LJPC | LA JOLLA PHARMACEU ... | Gonzalez Alejandro | 10% Owner | Buy | P | 3.08 | 500 | 1,540 | 4,562,895 | 4.6 M to 4.6 M (+0.01 %) |
Jan 10 2007 | LJPC | LA JOLLA PHARMACEU ... | Gonzalez Alejandro | 10% Owner | Buy | P | 2.92 | 40,200 | 117,384 | 4,562,395 | 4.5 M to 4.6 M (+0.89 %) |
Jan 10 2007 | LJPC | LA JOLLA PHARMACEU ... | Gonzalez Alejandro | 10% Owner | Buy | P | 2.88 | 20,000 | 57,600 | 4,522,195 | 4.5 M to 4.5 M (+0.44 %) |
Jan 10 2007 | LJPC | LA JOLLA PHARMACEU ... | Gonzalez Alejandro | 10% Owner | Buy | P | 3.56 | 15,000 | 53,400 | 4,502,195 | 4.5 M to 4.5 M (+0.33 %) |
Jan 10 2007 | LJPC | LA JOLLA PHARMACEU ... | Gonzalez Alejandro | 10% Owner | Buy | P | 3.40 | 15,000 | 51,000 | 4,487,195 | 4.5 M to 4.5 M (+0.34 %) |
Jan 10 2007 | LJPC | LA JOLLA PHARMACEU ... | Gonzalez Alejandro | 10% Owner | Buy | P | 3.18 | 20,000 | 63,600 | 4,472,195 | 4.5 M to 4.5 M (+0.45 %) |
Jan 10 2007 | LJPC | LA JOLLA PHARMACEU ... | Gonzalez Alejandro | 10% Owner | Buy | P | 3.95 | 47,272 | 186,724 | 4,452,195 | 4.4 M to 4.5 M (+1.07 %) |
Jan 05 2007 | LJPC | LA JOLLA PHARMACEU ... | KOCH LISA I | Sr Dir Regulatory A ... | Sell | S | 3.02 | 1,181 | 3,571 | 10,251 | 11.4 K to 10.3 K (-10.33 %) |
Jan 05 2007 | LJPC | LA JOLLA PHARMACEU ... | KOCH LISA I | Sr Dir Regulatory A ... | Buy | J | 3.06 | 247 | 756 | 11,432 | 11.2 K to 11.4 K (+2.21 %) |
Jan 05 2007 | LJPC | LA JOLLA PHARMACEU ... | KOCH LISA I | Sr Dir Regulatory A ... | Buy | J | 3.06 | 211 | 646 | 11,185 | 11 K to 11.2 K (+1.92 %) |
Jan 03 2007 | LJPC | LA JOLLA PHARMACEU ... | JENN PAUL | VP of Product Devel ... | Sell | S | 3.11 | 5,000 | 15,541 | 6,804 | 11.8 K to 6.8 K (-42.36 %) |
Dec 27 2006 | LJPC | LA JOLLA PHARMACEU ... | LINNIK MATTHEW D | CSO & Exec VP of Re ... | Sell | S | 3.03 | 365 | 1,106 | 1,300 | 1.7 K to 1.3 K (-21.92 %) |
Dec 27 2006 | LJPC | LA JOLLA PHARMACEU ... | LINNIK MATTHEW D | CSO & Exec VP of Re ... | Sell | S | 2.88 | 5,000 | 14,394 | 1,665 | 6.7 K to 1.7 K (-75.02 %) |
Dec 20 2006 | LJPC | LA JOLLA PHARMACEU ... | LINNIK MATTHEW D | CSO & Exec VP of Re ... | Sell | D | 3.00 | 2,500 | 7,500 | 6,665 | 9.2 K to 6.7 K (-27.28 %) |
Dec 20 2006 | LJPC | LA JOLLA PHARMACEU ... | LINNIK MATTHEW D | CSO & Exec VP of Re ... | Sell | D | 3.01 | 3,500 | 10,530 | 9,165 | 12.7 K to 9.2 K (-27.64 %) |
Dec 20 2006 | LJPC | LA JOLLA PHARMACEU ... | SMITH CRAIG R | Director | Grant | A | 2.99 | 3,600 | 10,764 | 23,600 | 20 K to 23.6 K (+18.00 %) |
Dec 18 2006 | LJPC | LA JOLLA PHARMACEU ... | LINNIK MATTHEW D | CSO & Exec VP of Re ... | Sell | D | 3.02 | 7,500 | 22,625 | 12,665 | 20.2 K to 12.7 K (-37.19 %) |
Dec 18 2006 | LJPC | LA JOLLA PHARMACEU ... | LINNIK MATTHEW D | CSO & Exec VP of Re ... | Sell | D | 3.12 | 1,500 | 4,680 | 20,165 | 21.7 K to 20.2 K (-6.92 %) |
Dec 18 2006 | LJPC | LA JOLLA PHARMACEU ... | JENN PAUL | VP of Product Devel ... | Sell | D | 3.12 | 1,500 | 4,680 | 11,804 | 13.3 K to 11.8 K (-11.27 %) |
Dec 18 2006 | LJPC | LA JOLLA PHARMACEU ... | JENN PAUL | VP of Product Devel ... | Buy | J | 3.06 | 174 | 532 | 13,304 | 13.1 K to 13.3 K (+1.33 %) |
Dec 18 2006 | LJPC | LA JOLLA PHARMACEU ... | JENN PAUL | VP of Product Devel ... | Gift | G | 0.00 | 1,819 | 0 | 13,130 | 14.9 K to 13.1 K (-12.17 %) |
Dec 18 2006 | LJPC | LA JOLLA PHARMACEU ... | JENN PAUL | VP of Product Devel ... | Buy | J | 3.06 | 148 | 453 | 14,949 | 14.8 K to 14.9 K (+1.00 %) |
Dec 05 2006 | LJPC | LA JOLLA PHARMACEU ... | TANSEY MICHAEL JAMES BYRON | Chief Medical Offic ... | Option Exercise | A | 3.23 | 87,000 | 281,010 | 87,000 | |
Dec 01 2006 | LJPC | LA JOLLA PHARMACEU ... | MARTIN STEPHEN | Director | Option Exercise | A | 3.25 | 2,000 | 6,500 | 2,000 | |
Dec 01 2006 | LJPC | LA JOLLA PHARMACEU ... | ADAMS THOMAS PHD | Director | Option Exercise | A | 3.25 | 8,000 | 26,000 | 8,000 | |
Dec 01 2006 | LJPC | LA JOLLA PHARMACEU ... | FILDES ROBERT PHD | Director | Option Exercise | A | 3.25 | 1,000 | 3,250 | 1,000 | |
Jul 18 2006 | LJPC | LA JOLLA PHARMACEU ... | TANSEY MICHAEL JAMES BYRON | Chief Medical Offic ... | Option Exercise | A | 3.61 | 113,000 | 407,930 | 113,000 | |
May 22 2006 | LJPC | LA JOLLA PHARMACEU ... | YOUNG FRANK | Director | Option Exercise | A | 3.99 | 8,000 | 31,920 | 8,000 | |
May 22 2006 | LJPC | LA JOLLA PHARMACEU ... | YOUNG FRANK | Director | Option Exercise | A | 3.99 | 2,000 | 7,980 | 2,000 | |
May 22 2006 | LJPC | LA JOLLA PHARMACEU ... | Topper James N | Director | Option Exercise | A | 3.99 | 8,000 | 31,920 | 8,000 | |
May 22 2006 | LJPC | LA JOLLA PHARMACEU ... | Topper James N | Director | Option Exercise | A | 3.99 | 2,000 | 7,980 | 2,000 | |
May 22 2006 | LJPC | LA JOLLA PHARMACEU ... | SUTTER MARTIN P | Director | Option Exercise | A | 3.99 | 8,000 | 31,920 | 8,000 | |
May 22 2006 | LJPC | LA JOLLA PHARMACEU ... | SUTTER MARTIN P | Director | Option Exercise | A | 3.99 | 2,000 | 7,980 | 2,000 | |
May 22 2006 | LJPC | LA JOLLA PHARMACEU ... | SMITH CRAIG R | Director | Option Exercise | A | 3.99 | 8,000 | 31,920 | 8,000 | |
May 22 2006 | LJPC | LA JOLLA PHARMACEU ... | SMITH CRAIG R | Director | Option Exercise | A | 3.99 | 12,000 | 47,880 | 12,000 | |
May 22 2006 | LJPC | LA JOLLA PHARMACEU ... | Naini Nader J | Director | Option Exercise | A | 3.99 | 8,000 | 31,920 | 8,000 | |
May 22 2006 | LJPC | LA JOLLA PHARMACEU ... | Naini Nader J | Director | Option Exercise | A | 3.99 | 2,000 | 7,980 | 2,000 | |
May 22 2006 | LJPC | LA JOLLA PHARMACEU ... | MARTIN STEPHEN | Director | Option Exercise | A | 3.99 | 30,000 | 119,700 | 30,000 | |
May 22 2006 | LJPC | LA JOLLA PHARMACEU ... | MARTIN STEPHEN | Director | Option Exercise | A | 3.99 | 8,000 | 31,920 | 8,000 | |
May 22 2006 | LJPC | LA JOLLA PHARMACEU ... | MARTIN STEPHEN | Director | Option Exercise | A | 3.99 | 2,000 | 7,980 | 2,000 | |
May 22 2006 | LJPC | LA JOLLA PHARMACEU ... | FILDES ROBERT PHD | Director | Option Exercise | A | 3.99 | 30,000 | 119,700 | 30,000 | |
May 22 2006 | LJPC | LA JOLLA PHARMACEU ... | FILDES ROBERT PHD | Director | Option Exercise | A | 3.99 | 8,000 | 31,920 | 8,000 | |
May 22 2006 | LJPC | LA JOLLA PHARMACEU ... | FILDES ROBERT PHD | Director | Option Exercise | A | 3.99 | 2,000 | 7,980 | 2,000 | |
May 22 2006 | LJPC | LA JOLLA PHARMACEU ... | ADAMS THOMAS PHD | Director | Option Exercise | A | 3.99 | 30,000 | 119,700 | 30,000 | |
May 22 2006 | LJPC | LA JOLLA PHARMACEU ... | ADAMS THOMAS PHD | Director | Option Exercise | A | 3.99 | 8,000 | 31,920 | 8,000 | |
May 22 2006 | LJPC | LA JOLLA PHARMACEU ... | ADAMS THOMAS PHD | Director | Option Exercise | A | 3.99 | 2,000 | 7,980 | 2,000 | |
Apr 18 2006 | LJPC | LA JOLLA PHARMACEU ... | REILLY TEDDI | VP of Human Resourc ... | Buy | J | 3.06 | 164 | 502 | 5,330 | 5.2 K to 5.3 K (+3.17 %) |
Apr 18 2006 | LJPC | LA JOLLA PHARMACEU ... | BENNETT BRUCE K JR | VP of Manufacturing | Buy | J | 3.06 | 185 | 566 | 12,836 | 12.7 K to 12.8 K (+1.46 %) |
Apr 18 2006 | LJPC | LA JOLLA PHARMACEU ... | WISEMAN ANDREW | Sen Dir Investor Re ... | Option Exercise | A | 4.46 | 20,301 | 90,542 | 103,395 | |
Apr 18 2006 | LJPC | LA JOLLA PHARMACEU ... | WISEMAN ANDREW | Sen Dir Investor Re ... | Buy | J | 3.06 | 153 | 468 | 16,174 | 16 K to 16.2 K (+0.95 %) |
Apr 18 2006 | LJPC | LA JOLLA PHARMACEU ... | SLOAN GAIL A | VP of Finance | Option Exercise | A | 4.46 | 184,548 | 823,084 | 278,079 | |
Apr 18 2006 | LJPC | LA JOLLA PHARMACEU ... | SLOAN GAIL A | VP of Finance | Buy | J | 3.06 | 156 | 477 | 3,652 | 3.5 K to 3.7 K (+4.46 %) |
Apr 18 2006 | LJPC | LA JOLLA PHARMACEU ... | LINNIK MATTHEW D | CSO & Exec VP of Re ... | Option Exercise | A | 4.46 | 310,430 | 1,384,518 | 361,027 | |
Apr 18 2006 | LJPC | LA JOLLA PHARMACEU ... | JENN PAUL | VP of Product Devel ... | Option Exercise | A | 4.46 | 122,548 | 546,564 | 239,639 | |
Apr 18 2006 | LJPC | LA JOLLA PHARMACEU ... | JENN PAUL | VP of Product Devel ... | Buy | J | 3.06 | 174 | 532 | 14,801 | 14.6 K to 14.8 K (+1.19 %) |
Apr 18 2006 | LJPC | LA JOLLA PHARMACEU ... | Elchico Josefina T | VP Quality Operatio ... | Option Exercise | A | 4.46 | 115,760 | 516,290 | 159,759 |